274 related articles for article (PubMed ID: 31641867)
41. Current situation of biofuel production and its enhancement by CRISPR/Cas9-mediated genome engineering of microbial cells.
Javed MR; Noman M; Shahid M; Ahmed T; Khurshid M; Rashid MH; Ismail M; Sadaf M; Khan F
Microbiol Res; 2019 Feb; 219():1-11. PubMed ID: 30642460
[TBL] [Abstract][Full Text] [Related]
42. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
Li K; Cai D; Wang Z; He Z; Chen S
Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
[No Abstract] [Full Text] [Related]
43. Gene Editing in Sorghum Through Agrobacterium.
Sander JD
Methods Mol Biol; 2019; 1931():155-168. PubMed ID: 30652289
[TBL] [Abstract][Full Text] [Related]
44. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
[TBL] [Abstract][Full Text] [Related]
45. Gas Chromatography-Mass Spectrometry Microbial Metabolomics for Applications in Strain Optimization.
Smith ML; Miguez AM; Styczynski MP
Methods Mol Biol; 2019; 1927():179-189. PubMed ID: 30788792
[TBL] [Abstract][Full Text] [Related]
46. Cryptic Chemical Communication: Secondary Metabolic Responses Revealed by Microbial Co-culture.
Liu C; Kakeya H
Chem Asian J; 2020 Feb; 15(3):327-337. PubMed ID: 31957936
[TBL] [Abstract][Full Text] [Related]
47. Progress of CRISPR-Cas Based Genome Editing in Photosynthetic Microbes.
Naduthodi MIS; Barbosa MJ; van der Oost J
Biotechnol J; 2018 Sep; 13(9):e1700591. PubMed ID: 29396999
[TBL] [Abstract][Full Text] [Related]
48. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
[TBL] [Abstract][Full Text] [Related]
49. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
50. Metabolomics methods for the synthetic biology of secondary metabolism.
Nguyen QT; Merlo ME; Medema MH; Jankevics A; Breitling R; Takano E
FEBS Lett; 2012 Jul; 586(15):2177-83. PubMed ID: 22710183
[TBL] [Abstract][Full Text] [Related]
51. The Integration of Metabolomics and Next-Generation Sequencing Data to Elucidate the Pathways of Natural Product Metabolism in Medicinal Plants.
Scossa F; Benina M; Alseekh S; Zhang Y; Fernie AR
Planta Med; 2018 Aug; 84(12-13):855-873. PubMed ID: 29843183
[TBL] [Abstract][Full Text] [Related]
52. Multiplexed CRISPR-Cpf1-Mediated Genome Editing in Clostridium difficile toward the Understanding of Pathogenesis of C. difficile Infection.
Hong W; Zhang J; Cui G; Wang L; Wang Y
ACS Synth Biol; 2018 Jun; 7(6):1588-1600. PubMed ID: 29863336
[TBL] [Abstract][Full Text] [Related]
53. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
Guitart JR; Johnson JL; Chien WW
J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
[TBL] [Abstract][Full Text] [Related]
54. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
Salsman J; Masson JY; Orthwein A; Dellaire G
Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
[TBL] [Abstract][Full Text] [Related]
55. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
56. Gene editing and genetic engineering approaches for advanced probiotics: A review.
Yadav R; Kumar V; Baweja M; Shukla P
Crit Rev Food Sci Nutr; 2018 Jul; 58(10):1735-1746. PubMed ID: 28071925
[TBL] [Abstract][Full Text] [Related]
57. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
[No Abstract] [Full Text] [Related]
58. CRISPRing future medicines.
Grand Moursel L; Visser M; Servant G; Durmus S; Zuurmond AM
Expert Opin Drug Discov; 2021 Apr; 16(4):463-473. PubMed ID: 33322954
[No Abstract] [Full Text] [Related]
59. Recent Advances in Discovery of Lead Structures from Microbial Natural Products: Genomics- and Metabolomics-Guided Acceleration.
Sukmarini L
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925414
[TBL] [Abstract][Full Text] [Related]
60. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
